Investment Group Ltd. Apeiron serves as Executive at ATAI Life Sciences N.V., where they oversee executive responsibilities. Since joining the company, Investment Group Ltd. Apeiron has executed 13 insider transactions totaling $20.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 30, 2025 involved exercising options for 2,367,200 shares valued at $0.
Investment Group Ltd. Apeiron currently holds 53,412,414 shares of ATAI Life Sciences N.V. (ATAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Investment Group Ltd. Apeiron has been a net buyer of ATAI stock. They have purchased $20.9M and sold $0 worth of shares.
Investment Group Ltd. Apeiron's most recent insider trade was on Sep 30, 2025, when they sold 2,367,200 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.19 |
| Discretionary |
| Feb 6, 2024 | ANRO | $0 | Conversion | 251,881 | $N/A | Discretionary |
| Feb 6, 2024 | ANRO | $0 | Conversion | 674,658 | $N/A | Discretionary |
| Feb 23, 2023 | SNSE | $1.8K | Purchase | 1,100 | $1.60 | Discretionary |
| Feb 23, 2023 | SNSE | $1.8K | Purchase | 1,100 | $1.62 | Discretionary |
| Apr 21, 2022 | ATAI | $340.0K | Purchase | 68,688 | $4.95 | Discretionary |
| Apr 20, 2022 | ATAI | $344.6K | Purchase | 67,703 | $5.09 | Discretionary |
| Apr 19, 2022 | ATAI | $335.1K | Purchase | 65,315 | $5.13 | Discretionary |
| Apr 18, 2022 | ATAI | $277.6K | Purchase | 54,322 | $5.11 | Discretionary |
| Apr 14, 2022 | ATAI | $25.8K | Purchase | 4,967 | $5.19 | Discretionary |
| Apr 11, 2022 | ATAI | $260.5K | Purchase | 53,926 | $4.83 | Discretionary |
| Apr 8, 2022 | ATAI | $277.5K | Purchase | 57,689 | $4.81 | Discretionary |